promegapoietin
Term · Oncology and biomedicine · MLC-T-ONC-006961
A drug given during chemotherapy to increase blood cell regeneration. Promegapoietin is a colony-stimulating factor that stimulates the production of blood cells, especially platelets. It is a cytokine and belongs to the family of drugs called hematopoietic (blood-forming) agents.
| Identifier | MLC-T-ONC-006961 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006961",
"term": "promegapoietin",
"field": "Oncology and biomedicine",
"definition": "A drug given during chemotherapy to increase blood cell regeneration. Promegapoietin is a colony-stimulating factor that stimulates the production of blood cells, especially platelets. It is a cytokine and belongs to the family of drugs called hematopoietic (blood-forming) agents.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/promegapoietin/"
}
Record 13,696 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.